Give Online: Help shape patient care for generations to come.

Jeffrey Schwersenski, MD


Jeffrey Schwersenski, MD

Appointed: 1995

No Patient Satisfaction Reviews
Jeffrey Schwersenski, MD
Department: Neonatology
Location: Cleveland Clinic Main Campus
Mail Code M31
9500 Euclid Avenue
Cleveland, OH 44195
Jeffrey Schwersenski, MD
Department: Neonatology
Location: Hillcrest Hospital
Mail Code M31
6770 Mayfield Road
Mayfield Heights, OH 44124
Type of Doctor:
Children & Adolescents Only

Biographical Sketch

Jeffrey Schwersenski, MD, is a Staff Neonatologist at Cleveland Clinic. He was the first Neonatologist at Cleveland Clinic when Birthing Services opened in May of 1995. He has worked to upgrade services at Hillcrest Hospital to level 3 status (1996 to present). Dr. Schwersenski has been actively involved in the expansion and development of a new state of the art, single patient room level 3 neonatal intensive care unit at Hillcrest Hospital. He received the Dr. Edward R. Cerutti Award for Excellence in Breast Feeding Advocacy at Hillcrest Hospital in 2006.

Hillcrest Hospital is a member of the Vermont - Oxford Network, which maintains a database and outcomes for very low birthweight infants (birthweight 1500 grams). Dr. Schwersenski is the Team Leader for Hillcrest Hospital in this effort.

Physician Champion (Neonatal Team) representing Hillcrest Hospital in the Ohio Perinatal Quality Collaborative, Neonatal Improvement Project, the goal of which is Improving Perinatal care in Ohio.

Education & Fellowships

Fellowship - Jackson Memorial Hospital
Neonatal Fellow
Miami, FL USA
Residency - Medical Center of Delaware
Wilmington, DE USA
Residency - Red Cross War Memorial Children's Hospital
Cape Town
Residency - Tygerberg Hospital
Internship - Groote Schuur Hospital
Obstetrics & Gynecology
Cape Town
Medical School - University of Cape Town Faculty of Medicine
Cape Town South Africa
Undergraduate - University of Cape Town
Cape Town


  • Pediatrics
  • Pediatrics- Neonatal-Perinatal Medicine

Specialty Interests

Apnea follow up, infant seat safety, infections in newborns, nursing/lactation, quality improvement in neonatology


  • American Academy of Pediatrics, Perinatal Section
  • Committee on Fetus and Newborn, American Academy of Pediatrics, Ohio Perinatal Section

Treatment & Services

  • Cardiopulmonary Resuscitation (cpr)
  • Department of Neonatology
  • Fetal Care
  • Infant Seat Safety
  • Lumbar Puncture (Spinal Tap)
  • Medical Care Of Ill Newborns
  • Neonatal Intensive Care
  • Oxygen Therapy

Specialty in Diseases and Conditions

  • Infections in Newborns
  • Pediatric Neonatal Disorders

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/27/2016, Dr. Schwersenski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • Afrikaans
  • English